COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,874 Articles (22,568 medRxiv, 8,306 bioRxiv)

Most recent first Previous |  Page 1637: Articles 16361-16370  | Next

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males.
Croci, S., Venneri, M. A., Mantovani, S., Fallerini, C., Benetti, E., Picchiotti, N., Campolo, F., Imperatore, F., Palmieri, M., Daga, S., Gabbi, C., Montagnani, F., Beligni, G., Farias, T. D. J., Carriero, M. L., Di Sarno, L., Alaverdian, D., Aslaksen, S., Cubellis, M. V., Spiga, O., Baldassarri, M., Fava, F., Norman, P. J., Frullanti, E., Isidori, A. M., Amoroso, A., Mari, F., Furini, S., Mondelli, M., GEN-COVID Multicenter Study, , Chiariello, M., Renieri, A., Meloni, I.
10.1101/2021.03.23.21254158 — Posted: 2021-03-26
Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a fourplex real-time quantitative reverse transcription-PCR assays.
Durand, M., Thibault, P., Levesque, S., Brault, A., Carignan, A., Valiquette, L., Martin, P., Labbe, S.
10.1101/2021.03.23.21254196 — Posted: 2021-03-26
Endogenous interferon-beta but not interferon-alpha or interferon-lambda levels in upper respiratory tract predict clinical outcome in critical COVID-19 patients independent of viral load
MENEZES, S. M., Braz, M., Llorens-Rico, V., Wauters, J., Van Weyenbergh, J.
10.1101/2021.03.23.21253748 — Posted: 2021-03-26
Continuity of routine immunization programs in Canada during the COVID-19 pandemic
Sell, H., Assi, A., Driedger, M., Dube, E., Gagneur, A., Meyer, S. B., Robinson, J., Sadarangani, M., Tunis, M., MacDonald, S. E.
10.1101/2021.03.22.21254121 — Posted: 2021-03-26
Development of a Codebook of Online Anti-Vaccination Rhetoric to Manage COVID-19 Vaccine Misinformation
Hughes, B., Miller-Idriss, C., Piltch-Loeb, R., White, K., Criezis, M., Cain, C., Savoia, E.
10.1101/2021.03.23.21253727 — Posted: 2021-03-26 Discussion: Offsite
Testing and Vaccination to Reduce the Impact of COVID-19 in Nursing Homes: An Agent-Based Approach
Gomez-Vazquez, J. P., Garcia, y., Schmidt, A. J., Martinez-Lopez, B., Nuno, M.
10.1101/2021.03.22.21254125 — Posted: 2021-03-26
Feasibility and effectiveness of daily temperature screening to detect COVID-19 in a large public university setting
Facente, S. N., Hunter, L. A., Packel, L. J., Li, Y., Harte, A., Nicolette, G., McDevitt, S., Petersen, M., Reingold, A. L.
10.1101/2021.03.22.21254140 — Posted: 2021-03-26
Covid-19 High Attack Rate Can Lead to High Case Fatality Rate
Raham, T. F.
10.1101/2021.03.23.21254184 — Posted: 2021-03-26
Human IgG and IgA responses to COVID-19 mRNA vaccines
Campillo Luna, J., Wisnewski, A. V., Redlich, C. A.
10.1101/2021.03.23.21254060 — Posted: 2021-03-26 Discussion: Onsite
Characterizing the disproportionate burden of SARS-CoV-2 variants of concern among essential workers in the Greater Toronto Area, Canada
Chagla, Z., Ma, H., Sander, B., Baral, S., Mishra, S.
10.1101/2021.03.22.21254127 — Posted: 2021-03-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).